Side-by-side on funding, valuation, status, and the rest of the FOBI roster.
Reads and modulates the vagus nerve to treat chronic inflammatory diseases using implantable neural interfaces.
Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →
| Valuation |
| — |
$430MLatest valuation |
| Founders | Emil Hewage, Oliver Armitage | Grégoire Courtine, Jocelyne Bloch |
| Profile | View on FOBI → | View on FOBI → |